Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear receptor activity	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.59e-11	60	64	8	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.82e-11	61	64	8	GO:0098531
GeneOntologyMolecularFunction	nuclear steroid receptor activity	ESR2 NR4A3 NR3C1 RXRB	1.15e-06	25	64	4	GO:0003707
GeneOntologyMolecularFunction	zinc ion binding	ADAMTS9 ESR2 NR4A2 NR4A3 ZNFX1 NR3C1 HNF4A ZZEF1 HNF4G RXRB NR2F2 USP20 DNMT1	4.04e-06	891	64	13	GO:0008270
GeneOntologyMolecularFunction	transition metal ion binding	KDM3A ADAMTS9 ESR2 NR4A2 NR4A3 ZNFX1 NR3C1 HNF4A ZZEF1 HNF4G RXRB NR2F2 USP20 DNMT1	1.89e-05	1189	64	14	GO:0046914
GeneOntologyMolecularFunction	polysaccharide binding	CLEC18A CLEC18B CLEC18C	1.32e-04	31	64	3	GO:0030247
GeneOntologyMolecularFunction	olfactory receptor binding	RTP1 RTP2	1.50e-04	6	64	2	GO:0031849
GeneOntologyMolecularFunction	steroid hormone binding	ESR2 NR3C1	2.10e-04	7	64	2	GO:1990239
GeneOntologyMolecularFunction	nuclear receptor binding	KDM3A NR4A2 NR4A3 RXRB DNMT1	3.33e-04	187	64	5	GO:0016922
GeneOntologyMolecularFunction	estrogen response element binding	ESR2 NR3C1	5.46e-04	11	64	2	GO:0034056
GeneOntologyMolecularFunction	Hsp90 protein binding	AGO2 NR3C1 NOS2	7.31e-04	55	64	3	GO:0051879
GeneOntologyMolecularFunction	carboxylic acid binding	HNF4A NOS2 NR2F2 GFRA2 PMP2	1.01e-03	239	64	5	GO:0031406
GeneOntologyMolecularFunction	organic acid binding	HNF4A NOS2 NR2F2 GFRA2 PMP2	1.32e-03	254	64	5	GO:0043177
GeneOntologyMolecularFunction	glycosaminoglycan binding	BMP7 SULF2 STAB2 SPOCK2 GFRA2	1.68e-03	268	64	5	GO:0005539
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NR4A2 NR4A3	1.85e-03	20	64	2	GO:0035259
GeneOntologyMolecularFunction	double-stranded RNA binding	AGO2 AGO4 MBNL1	2.01e-03	78	64	3	GO:0003725
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB	2.05e-03	560	64	7	GO:0001228
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	KDM3A NR4A2 NR4A3 HNF4A RXRB DNMT1	2.16e-03	417	64	6	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB	2.18e-03	566	64	7	GO:0001216
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	KDM3A ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	5.23e-06	416	64	9	GO:0030522
GeneOntologyBiologicalProcess	siRNA-mediated post-transcriptional gene silencing	AGO2 AGO4	5.66e-05	4	64	2	GO:0140766
GeneOntologyBiologicalProcess	siRNA-mediated gene silencing by mRNA destabilization	AGO2 AGO4	5.66e-05	4	64	2	GO:0090625
HumanPheno	Severe viral infection	DOCK8 DEF6 ZNFX1 IL2RA	1.40e-05	36	22	4	HP:0031691
Domain	zf-C4	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	PF00105
Domain	Znf_hrmn_rcpt	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	IPR001628
Domain	Nuclear_hrmn_rcpt	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	IPR001723
Domain	NUCLEAR_REC_DBD_2	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	PS51030
Domain	NUCLEAR_REC_DBD_1	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	PS00031
Domain	ZnF_C4	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.90e-12	46	61	8	SM00399
Domain	-	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	2.29e-12	47	61	8	1.10.565.10
Domain	HOLI	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	2.74e-12	48	61	8	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	2.74e-12	48	61	8	IPR000536
Domain	Hormone_recep	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	2.74e-12	48	61	8	PF00104
Domain	-	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.17e-11	57	61	8	3.30.50.10
Domain	Znf_NHR/GATA	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.36e-11	58	61	8	IPR013088
Domain	COUP_TF	HNF4A HNF4G NR2F2	3.30e-07	5	61	3	IPR003068
Domain	Retinoid-X_rcpt/HNF4	HNF4A HNF4G RXRB	3.91e-06	10	61	3	IPR000003
Domain	-	CLEC18A CLEC18B CLEC18C	1.47e-05	15	61	3	3.40.33.10
Domain	CAP	CLEC18A CLEC18B CLEC18C	1.47e-05	15	61	3	PF00188
Domain	CAP_domain	CLEC18A CLEC18B CLEC18C	1.47e-05	15	61	3	IPR014044
Domain	SCP	CLEC18A CLEC18B CLEC18C	1.47e-05	15	61	3	SM00198
Domain	Allrgn_V5/Tpx1	CLEC18A CLEC18B CLEC18C	1.47e-05	15	61	3	IPR001283
Domain	Nuc_orph_rcpt	NR4A2 NR4A3	3.14e-05	3	61	2	IPR003070
Domain	Argonaute_N	AGO2 AGO4	6.27e-05	4	61	2	IPR032474
Domain	Argonaute_Mid_dom	AGO2 AGO4	6.27e-05	4	61	2	IPR032473
Domain	ArgoL2	AGO2 AGO4	6.27e-05	4	61	2	IPR032472
Domain	ArgoN	AGO2 AGO4	6.27e-05	4	61	2	PF16486
Domain	ArgoMid	AGO2 AGO4	6.27e-05	4	61	2	PF16487
Domain	ArgoL2	AGO2 AGO4	6.27e-05	4	61	2	PF16488
Domain	R-trans_p	RTP1 RTP2	1.04e-04	5	61	2	IPR026096
Domain	DUF1785	AGO2 AGO4	1.04e-04	5	61	2	SM01163
Domain	ArgoL1	AGO2 AGO4	1.56e-04	6	61	2	PF08699
Domain	ArgoL1	AGO2 AGO4	1.56e-04	6	61	2	IPR014811
Domain	zf-3CxxC	RTP1 RTP2	2.18e-04	7	61	2	PF13695
Domain	-	CLEC18A STAB2 CLEC18B CLEC18C	2.84e-04	97	61	4	3.10.100.10
Domain	zf-3CxxC	RTP1 RTP2	2.90e-04	8	61	2	SM01328
Domain	PIWI	AGO2 AGO4	2.90e-04	8	61	2	PS50822
Domain	Piwi	AGO2 AGO4	2.90e-04	8	61	2	SM00950
Domain	Znf-3CxxC	RTP1 RTP2	2.90e-04	8	61	2	IPR027377
Domain	Piwi	AGO2 AGO4	2.90e-04	8	61	2	IPR003165
Domain	Piwi	AGO2 AGO4	2.90e-04	8	61	2	PF02171
Domain	C-type_lectin-like/link	CLEC18A STAB2 CLEC18B CLEC18C	3.07e-04	99	61	4	IPR016186
Domain	PAZ	AGO2 AGO4	3.72e-04	9	61	2	PS50821
Domain	PAZ	AGO2 AGO4	3.72e-04	9	61	2	SM00949
Domain	PAZ_dom	AGO2 AGO4	3.72e-04	9	61	2	IPR003100
Domain	PAZ	AGO2 AGO4	3.72e-04	9	61	2	PF02170
Domain	C-type_lectin_CS	CLEC18A CLEC18B CLEC18C	3.73e-04	43	61	3	IPR018378
Domain	CTDL_fold	CLEC18A STAB2 CLEC18B CLEC18C	4.13e-04	107	61	4	IPR016187
Domain	-	AGO2 AGO4 POLD1	4.85e-04	47	61	3	3.30.420.10
Domain	-	STAB2 HMCN1	5.66e-04	11	61	2	2.40.155.10
Domain	GFP-like	STAB2 HMCN1	5.66e-04	11	61	2	IPR023413
Domain	EGF_3	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.01e-03	235	61	5	PS50026
Domain	EGF	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.01e-03	235	61	5	SM00181
Domain	EGF-like_dom	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.31e-03	249	61	5	IPR000742
Domain	Znf_FYVE_PHD	KDM3A KMT2C BAZ2B RFFL	1.36e-03	147	61	4	IPR011011
Domain	EGF_1	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.46e-03	255	61	5	PS00022
Domain	RNaseH-like_dom	AGO2 AGO4 POLD1	1.49e-03	69	61	3	IPR012337
Domain	EGF-like_CS	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.61e-03	261	61	5	IPR013032
Domain	EGF_2	CLEC18A STAB2 CLEC18B HMCN1 CLEC18C	1.72e-03	265	61	5	PS01186
Domain	C_TYPE_LECTIN_1	CLEC18A CLEC18B CLEC18C	2.28e-03	80	61	3	PS00615
Domain	Lectin_C	CLEC18A CLEC18B CLEC18C	2.62e-03	84	61	3	PF00059
Domain	CLECT	CLEC18A CLEC18B CLEC18C	2.62e-03	84	61	3	SM00034
Domain	C_TYPE_LECTIN_2	CLEC18A CLEC18B CLEC18C	2.71e-03	85	61	3	PS50041
Domain	C-type_lectin-like	CLEC18A CLEC18B CLEC18C	2.80e-03	86	61	3	IPR001304
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB	3.94e-10	53	47	7	M8276
Pathway	WP_NUCLEAR_RECEPTORS	ESR2 NR4A2 NR3C1 HNF4A RXRB NR2F2	2.51e-09	38	47	6	M39657
Pathway	WP_NUCLEAR_RECEPTORS	ESR2 NR4A2 NR3C1 HNF4A RXRB NR2F2	2.51e-09	38	47	6	MM15865
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	ESR2 NR4A2 NR4A3 NR3C1 HNF4A RXRB	1.09e-08	48	47	6	MM14987
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	KDM3A AGO2 AGO4 RXRB	6.61e-06	37	47	4	M29790
Pathway	REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION	AGO2 AGO4 NR3C1	9.70e-06	13	47	3	M46434
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	KDM3A AGO2 AGO4 RXRB	1.74e-05	47	47	4	M29777
Pathway	BIOCARTA_DICER_PATHWAY	AGO2 AGO4	1.08e-04	5	47	2	M22079
Pathway	WP_MALE_INFERTILITY	KDM3A AGO2 CLU ESR2 NOS2	1.16e-04	145	47	5	M39856
Pathway	REACTOME_MICRORNA_MIRNA_BIOGENESIS	AGO2 AGO4	1.62e-04	6	47	2	MM14818
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO2 AGO4	1.62e-04	6	47	2	MM15083
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	AGO2 AGO4 NR3C1	1.93e-04	34	47	3	M46422
Pathway	REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER	AGO2 AGO4 DNMT1	2.11e-04	35	47	3	M42525
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO2 AGO4	2.26e-04	7	47	2	M46421
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO2 AGO4	3.01e-04	8	47	2	MM15082
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO2 AGO4	3.86e-04	9	47	2	M27340
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	AGO2 AGO4	3.86e-04	9	47	2	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	AGO2 AGO4	3.86e-04	9	47	2	M46436
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	KMT2C AGO2 AGO4 ZNF550 ESR2 NR4A2 NR4A3 RFFL NR3C1 HNF4A HNF4G IL2RA RXRB	4.41e-04	1387	47	13	M734
Pathway	REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS	AGO2 AGO4	4.81e-04	10	47	2	M48013
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	KMT2C AGO2 AGO4 NR4A3 IL2RA	1.11e-03	237	47	5	M27786
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.37e-10	133	64	8	15604093
Pubmed	Nuclear receptors in Leydig cell gene expression and function.	ESR2 NR4A3 NR3C1 RXRB NR2F2	4.62e-10	22	64	5	20375256
Pubmed	A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development.	ESR2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	2.29e-09	118	64	7	16971476
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18A CLEC18B CLEC18C	5.94e-09	3	64	3	26170455
Pubmed	The C-type lectin-like domain superfamily.	CLEC18A CLEC18B CLEC18C	5.94e-09	3	64	3	16336259
Pubmed	Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.	CLEC18A CLEC18B CLEC18C	5.94e-09	3	64	3	33603190
Pubmed	The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.	CLEC18A CLEC18B CLEC18C	2.37e-08	4	64	3	16709836
Pubmed	The structure of the nuclear hormone receptors.	ESR2 NR3C1 RXRB	2.07e-07	7	64	3	10406480
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	5.62e-07	263	64	7	20932939
Pubmed	Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.	NR3C1 HNF4A NR2F2	1.68e-06	13	64	3	9115274
Pubmed	Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies.	AGO2 MAPKAPK2	3.33e-06	2	64	2	18476811
Pubmed	Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.	NR4A2 NR4A3	3.33e-06	2	64	2	34248958
Pubmed	Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids.	HNF4A HNF4G	3.33e-06	2	64	2	12220494
Pubmed	A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.	NR4A2 NR4A3	3.33e-06	2	64	2	36469101
Pubmed	Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes.	HNF4A HNF4G	3.33e-06	2	64	2	8622695
Pubmed	Receptor-transporting protein (RTP) family members play divergent roles in the functional expression of odorant receptors.	RTP1 RTP2	3.33e-06	2	64	2	28586385
Pubmed	The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.	AGO2 ESR2	3.33e-06	2	64	2	29017520
Pubmed	The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism.	NR3C1 NR2F2	3.33e-06	2	64	2	14739255
Pubmed	Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.	NR4A2 NR4A3	3.33e-06	2	64	2	32341238
Pubmed	Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ.	HNF4A HNF4G	3.33e-06	2	64	2	30224520
Pubmed	Glucose Tolerance Is Improved in Mice Invalidated for the Nuclear Receptor HNF-4γ: A Critical Role for Enteroendocrine Cell Lineage.	HNF4A HNF4G	3.33e-06	2	64	2	25829452
Pubmed	Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.	MBNL1 MBNL3	3.33e-06	2	64	2	10970838
Pubmed	Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.	NR3C1 HNF4A	3.33e-06	2	64	2	19540905
Pubmed	Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.	NR3C1 HNF4A	3.33e-06	2	64	2	17978169
Pubmed	Three-dimensional interactions between enhancers and promoters during intestinal differentiation depend upon HNF4.	HNF4A HNF4G	3.33e-06	2	64	2	33503426
Pubmed	Intestine-specific ablation of the Hepatocyte Nuclear Factor 4a (Hnf4a) gene in mice has minimal impact on serum lipids and ileum gene expression profile due to upregulation of its paralog Hnf4g.	HNF4A HNF4G	3.33e-06	2	64	2	34973414
Pubmed	Proteomic analysis of native hepatocyte nuclear factor-4α (HNF4α) isoforms, phosphorylation status, and interactive cofactors.	HNF4A HNF4G	3.33e-06	2	64	2	21047794
Pubmed	Orphan Nuclear Receptor Family 4A (NR4A) Members NR4A2 and NR4A3 Selectively Modulate Elements of the Monocyte Response to Buffered Hypercapnia.	NR4A2 NR4A3	3.33e-06	2	64	2	38474099
Pubmed	The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells.	HNF4A NR2F2	3.33e-06	2	64	2	18474611
Pubmed	Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.	NR3C1 HNF4A	3.33e-06	2	64	2	35614477
Pubmed	NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival.	NR4A2 NR4A3	3.33e-06	2	64	2	28637666
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KMT2C MBNL1 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	5.85e-06	709	64	9	22988430
Pubmed	A census of human transcription factors: function, expression and evolution.	ESR2 NR4A2 NR4A3 ZNFX1 NR3C1 HNF4A HNF4G RXRB NR2F2 MBNL3	5.92e-06	908	64	10	19274049
Pubmed	A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity.	HNF4A HNF4G	9.99e-06	3	64	2	30988513
Pubmed	NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors.	NR4A2 NR4A3	9.99e-06	3	64	2	22996661
Pubmed	Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.	NR4A2 NR4A3	9.99e-06	3	64	2	18945812
Pubmed	A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.	ADAMTS9 DNMT1	9.99e-06	3	64	2	24833086
Pubmed	Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II.	HNF4A NR2F2	9.99e-06	3	64	2	18765665
Pubmed	Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2.	ESR2 NOS2	9.99e-06	3	64	2	18753331
Pubmed	Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli.	NR4A2 NR4A3	9.99e-06	3	64	2	15964844
Pubmed	NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3.	NR4A2 NR3C1	9.99e-06	3	64	2	7877627
Pubmed	Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.	NR4A2 NR3C1	9.99e-06	3	64	2	15591535
Pubmed	DNMT1-mediated NR3C1 DNA methylation enables transcription activation of connexin40 and augments angiogenesis during colorectal cancer progression.	NR3C1 DNMT1	9.99e-06	3	64	2	37813207
Pubmed	Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS.	NR3C1 NOS2	9.99e-06	3	64	2	25135720
Pubmed	Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes.	NR3C1 HNF4A	9.99e-06	3	64	2	24399729
Pubmed	Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood.	MBNL1 MBNL3	9.99e-06	3	64	2	32332745
Pubmed	Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.	NR4A2 NR4A3	9.99e-06	3	64	2	10523643
Pubmed	Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.	NR4A2 NR4A3	9.99e-06	3	64	2	20659174
Pubmed	Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.	NR4A2 NR4A3	9.99e-06	3	64	2	36482877
Pubmed	NR4A transcription factors limit CAR T cell function in solid tumours.	NR4A2 NR4A3	9.99e-06	3	64	2	30814732
Pubmed	The NR4A orphan nuclear receptors: mediators in metabolism and diseases.	NR4A2 NR4A3	9.99e-06	3	64	2	25089663
Pubmed	Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins.	AGO2 AGO4	9.99e-06	3	64	2	19946268
Pubmed	Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues.	NR4A2 NR4A3	9.99e-06	3	64	2	19465082
Pubmed	MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling.	NR4A2 NR4A3	9.99e-06	3	64	2	15910281
Pubmed	Nuclear receptors of the NR4a family are not required for the development and function of follicular T helper cells.	NR4A2 NR4A3	9.99e-06	3	64	2	25899083
Pubmed	Unique response pathways are established by allosteric interactions among nuclear hormone receptors.	NR4A2 RXRB	9.99e-06	3	64	2	7758108
Pubmed	Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.	MBNL1 MBNL3	9.99e-06	3	64	2	19095965
Pubmed	Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.	NR4A2 NR4A3	9.99e-06	3	64	2	27159982
Pubmed	The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.	NR4A2 NR4A3	9.99e-06	3	64	2	22143616
Pubmed	Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.	MBNL1 MBNL3	9.99e-06	3	64	2	11929853
Pubmed	Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses.	NR4A2 NR4A3	9.99e-06	3	64	2	16873729
Pubmed	The nuclear receptor HNF4 drives a brush border gene program conserved across murine intestine, kidney, and embryonic yolk sac.	HNF4A HNF4G	9.99e-06	3	64	2	34001900
Pubmed	Muscleblind proteins regulate alternative splicing.	MBNL1 MBNL3	9.99e-06	3	64	2	15257297
Pubmed	Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.	MBNL1 MBNL3	9.99e-06	3	64	2	28698297
Pubmed	The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice.	NR4A2 NR4A3	9.99e-06	3	64	2	25605333
Pubmed	Distinct roles of estrogen receptor-alpha and beta in the modulation of vascular inducible nitric-oxide synthase in diabetes.	ESR2 NOS2	9.99e-06	3	64	2	18832649
Pubmed	Relevance of the NR4A sub-family of nuclear orphan receptors in trophoblastic BeWo cell differentiation.	NR4A2 NR4A3	9.99e-06	3	64	2	28808448
Pubmed	The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes.	NR4A2 NR4A3	9.99e-06	3	64	2	25199433
Pubmed	Analysis of polymorphisms in Interleukin 10, NOS2A, and ESR2 genes in chronic and aggressive periodontitis.	ESR2 NOS2	9.99e-06	3	64	2	27737359
Pubmed	NR4A nuclear receptors in immunity and atherosclerosis.	NR4A2 NR4A3	9.99e-06	3	64	2	24005216
Pubmed	Minireview: What is Known about SUMOylation Among NR4A Family Members?	NR4A2 NR4A3	9.99e-06	3	64	2	34437889
Pubmed	Control of energy balance by hypothalamic gene circuitry involving two nuclear receptors, neuron-derived orphan receptor 1 and glucocorticoid receptor.	NR4A3 NR3C1	9.99e-06	3	64	2	23897430
Pubmed	Stress and glucocorticoid regulation of NR4A genes in mice.	NR4A2 NR4A3	9.99e-06	3	64	2	24753204
Pubmed	Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation.	NR4A2 NR4A3	9.99e-06	3	64	2	21621845
Pubmed	Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.	MBNL1 MBNL3	9.99e-06	3	64	2	25263597
Pubmed	Nuclear receptor 4A (NR4A) family - orphans no more.	NR4A2 NR4A3	9.99e-06	3	64	2	25917081
Pubmed	FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.	NR4A2 NR4A3	9.99e-06	3	64	2	18809462
Pubmed	Hepatocyte nuclear factor-4 alpha/gamma and hepatocyte nuclear factor-1 alpha as causal factors of interindividual difference in the expression of human dihydrodiol dehydrogenase 4 mRNA in human livers.	HNF4A HNF4G	2.00e-05	4	64	2	12544512
Pubmed	Molecular dissection of human Argonaute proteins by DNA shuffling.	AGO2 AGO4	2.00e-05	4	64	2	23748378
Pubmed	Cryptotanshinone and wogonin up-regulate eNOS in vascular endothelial cells via ERα and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via ERβ.	ESR2 NOS2	2.00e-05	4	64	2	26481132
Pubmed	Regulation of vascular endothelial growth factor D by orphan receptors hepatocyte nuclear factor-4 alpha and chicken ovalbumin upstream promoter transcription factors 1 and 2.	HNF4A NR2F2	2.00e-05	4	64	2	18199540
Pubmed	Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.	ESR2 NR3C1	2.00e-05	4	64	2	17512111
Pubmed	TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.	NR4A2 NR4A3	2.00e-05	4	64	2	31152140
Pubmed	Trained immunity induced by high-salt diet impedes stroke recovery.	NR4A2 NR4A3	2.00e-05	4	64	2	37965920
Pubmed	The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.	HNF4A RXRB	2.00e-05	4	64	2	10594021
Pubmed	Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.	NR4A2 NR4A3	2.00e-05	4	64	2	37961948
Pubmed	Argonaute proteins: potential biomarkers for human colon cancer.	AGO2 AGO4	2.00e-05	4	64	2	20146808
Pubmed	Nr4a Receptors Regulate Development and Death of Labile Treg Precursors to Prevent Generation of Pathogenic Self-Reactive Cells.	NR4A2 NR4A3	2.00e-05	4	64	2	30089271
Pubmed	Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo.	NR4A2 NR4A3	2.00e-05	4	64	2	15910753
Pubmed	Slicing-independent RISC activation requires the argonaute PAZ domain.	AGO2 AGO4	2.00e-05	4	64	2	22795694
Pubmed	Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.	NR4A2 NR4A3	2.00e-05	4	64	2	14525795
Pubmed	NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection.	NR4A2 NR4A3	2.00e-05	4	64	2	20566846
Pubmed	Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.	AGO2 AGO4	2.00e-05	4	64	2	18771919
Pubmed	Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.	MLKL MAPKAPK2	2.00e-05	4	64	2	26859455
Pubmed	Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.	AGO2 AGO4	2.00e-05	4	64	2	15260970
Pubmed	Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis.	NR4A2 NR4A3	2.00e-05	4	64	2	23334790
Pubmed	Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.	NR4A2 NR4A3	2.00e-05	4	64	2	22789442
Pubmed	Olfactory receptor accessory proteins play crucial roles in receptor function and gene choice.	RTP1 RTP2	2.00e-05	4	64	2	28262096
Pubmed	Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.	MBNL1 MBNL3	2.00e-05	4	64	2	26501102
Pubmed	Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3.	MBNL1 MBNL3	2.00e-05	4	64	2	12915312
Interaction	IRF2BP1 interactions	KDM3A ESR2 MBNL1 NR3C1 HNF4A	4.25e-06	81	60	5	int:IRF2BP1
Interaction	NCOA1 interactions	ESR2 NR4A2 NR3C1 HNF4A HNF4G RXRB	4.73e-06	146	60	6	int:NCOA1
Interaction	NR0B2 interactions	ESR2 NR3C1 HNF4A HNF4G RXRB	4.80e-06	83	60	5	int:NR0B2
Interaction	TRIM24 interactions	MLKL AGO2 AGO4 ZNF550 ESR2 NR3C1 HNF4A NR2F2	2.25e-05	398	60	8	int:TRIM24
Interaction	PNRC1 interactions	ESR2 HNF4A HNF4G	4.26e-05	23	60	3	int:PNRC1
Interaction	NCOA3 interactions	BMP7 ESR2 NR3C1 HNF4A HNF4G RXRB	5.35e-05	224	60	6	int:NCOA3
Cytoband	3q27.3	RTP1 RTP2	2.89e-04	18	64	2	3q27.3
Cytoband	1p34	AGO4 LAPTM5	9.24e-04	32	64	2	1p34
Cytoband	Ensembl 112 genes in cytogenetic band chr20q13	BMP7 SULF2 ZNFX1 HNF4A	2.90e-03	422	64	4	chr20q13
GeneFamily	Nuclear hormone receptors	ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.29e-12	49	53	8	71
GeneFamily	Zinc fingers 3CxxC-type\|Receptor transporter proteins	RTP1 RTP2	8.38e-05	5	53	2	719
GeneFamily	Zinc fingers 3CxxC-type\|Receptor transporter proteins	RTP1 RTP2	2.33e-04	8	53	2	137
GeneFamily	Argonaute/PIWI family	AGO2 AGO4	2.33e-04	8	53	2	408
GeneFamily	C-type lectin domain family	CLEC18A CLEC18B CLEC18C	3.52e-04	47	53	3	494
GeneFamily	Zinc fingers CCCH-type	MBNL1 MBNL3	4.72e-03	35	53	2	73
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	DOCK8 MBNL1 DEF6 NR4A2 SPOCK2 NR3C1 ADCY7 USP20 MBNL3 DNMT1 LAPTM5	9.93e-06	911	63	11	M40038
Coexpression	TRAVAGLINI_LUNG_LYMPHATIC_CELL	STAB2 CLU SGCE NR2F2 FAM162B LAPTM5	1.11e-05	209	63	6	M41670
Coexpression	FAN_EMBRYONIC_CTX_ASTROCYTE_2	KMT2C CLU SPOCK2 NR2F2 PMP2	3.50e-05	154	63	5	M39034
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL	SULF2 STAB2 CLU DOCK8 SGCE FAM162B LAPTM5	3.63e-05	382	63	7	M45756
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ZBTB44 KMT2C DOCK8 MBNL1 DEF6 NR4A2 SPOCK2 ZNFX1 NR3C1 ADCY7 USP20 DNMT1 LAPTM5	4.53e-05	1492	63	13	M40023
Coexpression	GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	ZBTB44 KMT2C AGO4 ZNF550 RXRB	1.05e-04	194	63	5	M3321
Coexpression	GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	SULF2 BAZ2B ADCY7 RXRB MBNL3	1.21e-04	200	63	5	M8056
Coexpression	GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	KMT2C GPR75 DGKZ ARHGEF4 NR3C1	1.21e-04	200	63	5	M8954
Coexpression	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	DOCK8 MBNL1 ARHGEF4 NR3C1 IL2RA	1.21e-04	200	63	5	M7992
Coexpression	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN	IQCH MYO1H GPR75 ARHGEF9 ZNFX1	1.21e-04	200	63	5	M7508
Coexpression	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	SULF2 DOCK8 BAZ2B NR4A2 ZZEF1	1.21e-04	200	63	5	M6096
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100	CLEC18A CLEC18B ADAMTS9 CLEC18C NOS2 NR2F2	4.66e-07	100	62	6	PCBC_ratio_ECTO_vs_SC_100
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	CLEC18A BMP7 CLEC18B CLU ADAMTS9 DOCK8 ARHGEF9 CLEC18C SGCE ARHGEF4 RXRB NR2F2 USP20	1.10e-05	1075	62	13	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	CLEC18A BMP7 SULF2 AGO4 CLEC18B CLU ADAMTS9 DOCK8 MAPKAPK2 CLEC18C SGCE ARHGEF4 RXRB NR2F2 USP20	1.52e-05	1466	62	15	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ZBTB44 KMT2C SULF2 AGO2 ADAMTS9 BAZ2B SGCE NR3C1 NR2F2 MBNL3 LAPTM5	1.80e-05	801	62	11	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05	CLEC18A CLEC18B ADAMTS9 DOCK8 KREMEN2 CLEC18C	1.87e-05	189	62	6	PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05
CoexpressionAtlas	ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05	CLEC18A BMP7 CLEC18B DOCK8 CLEC18C	2.45e-05	118	62	5	PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	ZBTB44 KMT2C ADAMTS9 NR3C1 MBNL3	3.48e-05	127	62	5	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2	CLU ADAMTS9 PTPRQ NOS2	5.23e-05	70	62	4	GSM777041_100
CoexpressionAtlas	Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05	CLEC18A CLEC18B DOCK8 CLEC18C	7.99e-05	78	62	4	PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	SULF2 HMCN1 CLU ADAMTS9 NR2F2 GFRA2 MBNL3	8.98e-05	364	62	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	SULF2 HMCN1 CLU ADAMTS9 MAPKAPK2 ARHGEF9 NR4A2 NR2F2 GFRA2 MBNL3	9.23e-05	793	62	10	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500	CLEC18A CLEC18B ADAMTS9 DOCK8 CLEC18C NR4A3 NOS2 NR2F2	9.23e-05	495	62	8	PCBC_ratio_ECTO_vs_SC_500
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_1000	SULF2 HMCN1 SPOCK2	1.11e-04	32	62	3	gudmap_kidney_adult_RenalCapsule_k1_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000	ZBTB44 ADAMTS9 NR3C1 MBNL3	1.40e-04	90	62	4	gudmap_developingGonad_P2_epididymis_1000_k4
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	KDM3A SULF2 HMCN1 CLU ADAMTS9 MAPKAPK2 NR4A2 NR4A3 NR2F2 MBNL3	1.61e-04	849	62	10	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05	CLEC18A BMP7 CLEC18B DOCK8 KREMEN2 CLEC18C	1.78e-04	284	62	6	PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000	ZBTB44 KMT2C ADAMTS9 MBNL3	1.86e-04	97	62	4	gudmap_developingGonad_e18.5_epididymis_1000_k4
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_100	CLEC18A CLEC18B CLEC18C NOS2	1.94e-04	98	62	4	PCBC_ECTO_blastocyst_100
CoexpressionAtlas	kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_500	SULF2 HMCN1 SPOCK2	2.17e-04	40	62	3	gudmap_kidney_P0_CapMes_Crym_k1_500
CoexpressionAtlas	Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05	CLEC18A CLEC18B DOCK8 CLEC18C	2.26e-04	102	62	4	PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	SULF2 HMCN1 NR2F2 GFRA2	2.72e-04	107	62	4	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500	ZBTB44 ADAMTS9 MBNL3	3.08e-04	45	62	3	gudmap_developingGonad_e16.5_epididymis_500_k3
CoexpressionAtlas	kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100	HMCN1 SPOCK2	3.72e-04	10	62	2	gudmap_kidney_P1_CapMes_Crym_k2_100
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000	CLEC18A BMP7 CLU POLD1 SCEL	3.86e-04	212	62	5	gudmap_developingKidney_e15.5_S-shaped body_1000_k1
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	MLKL SULF2 HMCN1 CLU MBNL1 PTPRQ SPOCK2 NR3C1 LAPTM5	4.04e-04	778	62	9	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	ZBTB44 KMT2C AGO2 ADAMTS9 SGCE NR3C1 ADCY7 NR2F2 MBNL3	4.52e-04	790	62	9	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	CLEC18A BMP7 CLEC18B DOCK8 CLEC18C NR4A3 NOS2	5.29e-04	487	62	7	PCBC_ECTO_blastocyst_500
CoexpressionAtlas	kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_100	HMCN1 SPOCK2	5.43e-04	12	62	2	gudmap_kidney_P0_CapMes_Crym_k1_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	SULF2 HMCN1 NR2F2 GFRA2	5.69e-04	130	62	4	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000	STAB2 HMCN1 ADAMTS9 DOCK8 SCN1B ARHGEF9 NR4A2 DGKZ LAPTM5	5.76e-04	817	62	9	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	SULF2 HMCN1 CLU ADAMTS9 NR2F2 GFRA2	5.94e-04	356	62	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000	BMP7 AGO2 HMCN1 SPOCK2 NR2F2	6.28e-04	236	62	5	gudmap_kidney_P3_CapMes_Crym_k1_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	SULF2 HMCN1 CLU NR2F2 GFRA2 MBNL3	6.39e-04	361	62	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_500	CLEC18A HMCN1 CLU ADAMTS9 SPOCK2 NR2F2	7.26e-04	370	62	6	gudmap_kidney_P3_CapMes_Crym_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	KDM3A SULF2 HMCN1 CLU GFRA2 MBNL3	7.47e-04	372	62	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	SULF2 HMCN1 CLU NR2F2 GFRA2 MBNL3	7.57e-04	373	62	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000	SULF2 AGO2 NR2F2	7.93e-04	62	62	3	gudmap_developingGonad_e11.5_testes_k4_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000	SULF2 AGO2 NR2F2	8.31e-04	63	62	3	gudmap_developingGonad_e11.5_testes and mesonephros_k1_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500	MLKL STAB2 DOCK8 DGKZ ADCY7 LAPTM5	8.81e-04	384	62	6	DevelopingKidney_e15.5_Endothelial cells_emap-29977_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500	KDM3A HMCN1 CLU NR4A2 GFRA2 MBNL3	8.93e-04	385	62	6	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000	SULF2 HMCN1 SPOCK2	9.52e-04	66	62	3	gudmap_kidney_P2_CapMes_Crym_k3_1000
ToppCell	IPF-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	STAB2 HMCN1 DOCK8 SGCE NR2F2 FAM162B LAPTM5	1.30e-08	195	64	7	de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 POLD1 DEF6 NR4A3 ADCY7 LAPTM5	1.44e-08	198	64	7	ba3b97bb3e1533df758e845bde7d82eb1525b057
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK8 SCN1B DEF6 SPOCK2 IL2RA LAPTM5	3.11e-07	189	64	6	78dcda09109a5cfb04ba069f16ec80987b3ad432
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 NR4A2 SPOCK2 IL2RA LAPTM5	3.51e-07	193	64	6	f3eb295a019de29f484964f00ea436860af249a5
ToppCell	distal-1-Endothelial-Lymphatic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RTP1 STAB2 CLU ADAMTS9 SLC13A5 NR2F2	4.08e-07	198	64	6	b6fea363463c8dd7e6780c085ece4900266a6286
ToppCell	LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T\|LPS_only / Treatment groups by lineage, cell group, cell type	DOCK8 MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	4.08e-07	198	64	6	584dbfeb0bb0358d3757aee56184e91ba35247ae
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 DEF6 NR4A3 IL2RA LAPTM5	4.08e-07	198	64	6	d11097254791e415bf60a847feac81f400f11664
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 NR4A3 IL2RA ADCY7 LAPTM5	4.08e-07	198	64	6	b2c8d5956f8449df4b69fb1b30632253440f815e
ToppCell	LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DOCK8 MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	4.20e-07	199	64	6	618dc6425bb7b84d3b2de7cf8ecb41549a255718
ToppCell	LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells\|LPS_only / Treatment groups by lineage, cell group, cell type	DOCK8 MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	4.20e-07	199	64	6	bd7f03bef4660c347da5f16db34d91d563908448
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Vein\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HMCN1 CLU ADAMTS9 SCN1B SPOCK2 NR2F2	4.20e-07	199	64	6	cfb624c7728046fc7f3ef071f57e4d7b013f3fef
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SULF2 MAPKAPK2 POLD1 NR4A2 NR4A3 ADCY7	4.33e-07	200	64	6	6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	RTP1 ADAMTS9 SGCE SPOCK2 SCEL	5.32e-06	175	64	5	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 SPOCK2 NR3C1 IL2RA LAPTM5	6.27e-06	181	64	5	a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK8 DEF6 NR4A2 SPOCK2 IL2RA	6.62e-06	183	64	5	450c30d2e389fcb17825394c27f9ccc4f33022e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP7 SULF2 ADAMTS9 PTPRQ SPOCK2	6.62e-06	183	64	5	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP7 SULF2 ADAMTS9 PTPRQ SPOCK2	6.62e-06	183	64	5	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)\|390C / Donor, Lineage, Cell class and subclass (all cells)	SULF2 STAB2 ADAMTS9 NR2F2 FAM162B	7.54e-06	188	64	5	aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	SULF2 STAB2 ADAMTS9 NR2F2 FAM162B	7.54e-06	188	64	5	1f40b959777d18ad88d239df8cca304f062ba04c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 MBNL1 DEF6 SPOCK2 ADCY7	7.94e-06	190	64	5	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 MBNL1 DEF6 SPOCK2 ADCY7	7.94e-06	190	64	5	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMCN1 ADAMTS9 SCN1B SPOCK2 NR2F2	8.35e-06	192	64	5	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HMCN1 CLU SGCE GFRA2 PMP2	8.78e-06	194	64	5	d429bb5e422a07bd92f0dc48cd51528e8b7d9a72
ToppCell	10x5'v1-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STAB2 HMCN1 ADAMTS9 NOS2 NR2F2	8.78e-06	194	64	5	e141beafc9252e5d8c949252bfab53e127c881dc
ToppCell	10x5'v1-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STAB2 HMCN1 ADAMTS9 NOS2 NR2F2	8.78e-06	194	64	5	953578102ffc7b612ee8fce45e414750800fef5d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 MBNL1 DEF6 SPOCK2 ADCY7	8.78e-06	194	64	5	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	ASK440-Endothelial-Lymphatic\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SULF2 STAB2 CLU SGCE NR2F2	8.78e-06	194	64	5	4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HMCN1 CLU SGCE GFRA2 PMP2	8.78e-06	194	64	5	bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HMCN1 CLU SGCE GFRA2 PMP2	8.78e-06	194	64	5	408dfc7060095972a54ae37ae8105521df6fbbee
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STAB2 HMCN1 ADAMTS9 NOS2 NR2F2	9.00e-06	195	64	5	22a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	STAB2 SGCE NR2F2 FAM162B LAPTM5	9.00e-06	195	64	5	fc75f04eb475c8139cc5c35e6be22e73fb2be9e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 DEF6 IL2RA ADCY7 LAPTM5	9.00e-06	195	64	5	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	343B-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	STAB2 SGCE NR2F2 FAM162B LAPTM5	9.00e-06	195	64	5	83d45ff5e5bc704448431149fffb2e4c1278f279
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK8 NR4A2 NR4A3 NR3C1 LAPTM5	9.23e-06	196	64	5	96407d51cb19d785b98c61a626b7cb167483ec4d
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MLKL DOCK8 DEF6 ADCY7 LAPTM5	9.23e-06	196	64	5	ce3709adbde7559b40c964888935914f66003247
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	SULF2 DOCK8 ADCY7 GFRA2 LAPTM5	9.23e-06	196	64	5	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	distal-Endothelial-Lymphatic\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 STAB2 CLU SGCE NR2F2	9.23e-06	196	64	5	3e8a20e1d163dcbd3bbd99fe179d54af02298af0
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	STAB2 SGCE NR2F2 FAM162B LAPTM5	9.23e-06	196	64	5	b04ca69b0ed44e09c989b575f747e1e819cd8008
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	STAB2 SGCE NR2F2 FAM162B LAPTM5	9.23e-06	196	64	5	a31e227de2dc077b81881295b012d22fedbd65ed
ToppCell	distal-Endothelial-Lymphatic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RTP1 STAB2 CLU SLC13A5 NR2F2	9.23e-06	196	64	5	b0f23dc802a2c2a56a08d398a464ea78b58ade4c
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SULF2 MAPKAPK2 POLD1 NR4A2 ADCY7	9.46e-06	197	64	5	8fa38fb95e285f9cc756ec4f32009be4ede09d3c
ToppCell	5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMP7 CLU HNF4A HNF4G FAM162B	9.46e-06	197	64	5	6ee6939c492bedf1f96a715da7a26a4c55a7c36f
ToppCell	distal-3-Endothelial-Lymphatic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 STAB2 CLU SGCE NR2F2	9.46e-06	197	64	5	9ea0e2ed9c3f97591a06e70570640996580417d5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 MBNL1 DEF6 ADCY7 LAPTM5	9.46e-06	197	64	5	61ef3f417767c3f5296a26399da63e3e4f58faf8
ToppCell	distal-Endothelial-Lymphatic-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 STAB2 CLU SGCE NR2F2	9.46e-06	197	64	5	8f2e19409ebe9a490d5a245fa82c765ed6d77c3e
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SCN1B DEF6 NR4A2 IL2RA RXRB	9.46e-06	197	64	5	cd9172af705f9589890252ab5e8b333ed754bea4
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells\|LPS_only / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 POLD1 NR4A3 IL2RA	9.46e-06	197	64	5	59ddd8ff7dddf3747b988374e1a4d80959db803e
ToppCell	mLN-T_cell-Activated_CD4_T\|T_cell / Region, Cell class and subclass	SULF2 MAPKAPK2 NR4A2 NR4A3 NR3C1	9.69e-06	198	64	5	404ec46bd39b6f4d02a03ef38c30850bbbd8b608
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	SULF2 MAPKAPK2 POLD1 NR4A2 NR4A3	9.69e-06	198	64	5	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	normal_Lung-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	SCN1B NR4A2 NR4A3 IL2RA GFRA2	9.69e-06	198	64	5	fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 POLD1 NR4A3 ADCY7	9.69e-06	198	64	5	436f3a9ef31b0991765bb97c21960f20fa71d578
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SULF2 DOCK8 DEF6 NR4A3 LAPTM5	9.69e-06	198	64	5	e8002972410e4803d85263ba2642e6855cef83e9
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	9.93e-06	199	64	5	b01328a80db5bb088c44564cea0f6729b1a9805b
ToppCell	FLU-Healthy-4\|Healthy / Virus stimulation, Condition and Cluster	KDM3A AGO2 NR4A2 NR4A3 NR3C1	9.93e-06	199	64	5	40061131e35131873192ca65c0e731a7b3045636
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SULF2 STAB2 SGCE NR2F2 FAM162B	9.93e-06	199	64	5	1587d24b19f5bb64a3b6cc1df87c7c472cf41672
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SULF2 STAB2 SGCE NR2F2 FAM162B	9.93e-06	199	64	5	a9c2041e54899cb8ccc026758647f3ae3ca457dd
ToppCell	Biopsy_Other_PF-Endothelial-Lymphatic_Endothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SULF2 STAB2 CLU SGCE NR2F2	9.93e-06	199	64	5	aa80c77fe4f6a141c780c7d8ecfff5d5a1c3b845
ToppCell	5'-GW_trimst-2-LymphNode\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	9.93e-06	199	64	5	4a9ca133125dc25a06e7b1cfea15ecffa449c20e
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	9.93e-06	199	64	5	45d0d275ffb4183e3e71f4701e121ef9853ebd10
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MLKL KMT2C DOCK8 ZNFX1 LAPTM5	9.93e-06	199	64	5	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SULF2 POLD1 NR4A2 ADCY7 LAPTM5	9.93e-06	199	64	5	f197ab861767ee06aa47b86c537fb3d8c2b2bc3e
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 NR4A2 SPOCK2 LAPTM5	9.93e-06	199	64	5	da20998253ad08a4a127a98b991b26237edb61a2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK8 NR4A2 NR4A3 ADCY7 LAPTM5	9.93e-06	199	64	5	e245851a5bddf56f7e13a7fb7c5fda2fd275dae3
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KMT2C AGO4 HMCN1 BAZ2B DGKZ	1.02e-05	200	64	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	HMCN1 CLU SCN1B MBNL1 NR2F2	1.02e-05	200	64	5	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	CLU ADAMTS9 SCN1B MBNL1 NR2F2	1.02e-05	200	64	5	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Vein\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CLU ADAMTS9 SCN1B SPOCK2 NR2F2	1.02e-05	200	64	5	b3f93b71589251197cde96b7bc6d065c106f61cd
ToppCell	distal-Hematologic-EREG+_Dendritic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NR4A2 NR4A3 ZZEF1 IL2RA GFRA2	1.02e-05	200	64	5	7809c74a2e52768854b66a135522138281bc4449
ToppCell	distal-Endothelial-Vein-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	ff88d28162e0231d5dac0e0c6bec98fa8da58a23
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS9 ANKRD62 SGCE NR2F2 FAM162B	1.02e-05	200	64	5	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	medial-Endothelial-Vein-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	3f689029f5bc7db0af50a405f1e252aeec529077
ToppCell	Biopsy_IPF-Immune-Monocytes\|Biopsy_IPF / Sample group, Lineage and Cell type	SULF2 DOCK8 NR4A2 NR4A3 LAPTM5	1.02e-05	200	64	5	80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50
ToppCell	distal-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	2785225956d2422acab90e99b7debe3709cf3308
ToppCell	medial-Endothelial-Vein\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	1163e5f6dfb304c94bf8885629350454f4b6bee8
ToppCell	distal-Endothelial-Vein\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	6acf7afe122f81a95c4c66f4d0878d997b57127a
ToppCell	medial-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SULF2 CLU ADAMTS9 SCN1B NR2F2	1.02e-05	200	64	5	49da4e3ff10262a492c2cf566a7f2e35e418bfda
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAPKAPK2 NR3C1 ADCY7 PMP2	5.97e-05	147	64	4	9566398275cad79223db90ffe640830acf2db864
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STAB2 MBNL1 IL2RA LAPTM5	6.62e-05	151	64	4	1525422afadff68a1525ced6d5db45fdea450678
ToppCell	facs-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULF2 SCN1B NR4A2 SCEL	7.70e-05	157	64	4	a84377028c661f8f3ecae0f6082abdd859faf0c8
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KREMEN2 DEF6 DNMT1 LAPTM5	8.09e-05	159	64	4	8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	AGO4 DOCK8 DEF6 PMP2	8.70e-05	162	64	4	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULF2 SCN1B ADCY7 GFRA2	8.91e-05	163	64	4	8dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh\|GI_large-bowel / Manually curated celltypes from each tissue	ZBTB44 SPOCK2 ZNFX1 NR3C1	8.91e-05	163	64	4	4104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULF2 SCN1B ADCY7 GFRA2	8.91e-05	163	64	4	fd243ca223079033be480a24817a399f281fa4d4
ToppCell	Club-club-16\|World / Class top	SULF2 HMCN1 ADAMTS9 HNF4G	9.34e-05	165	64	4	684f3c4872bd630d3f744f15d57dccfd34e96160
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMP7 STAB2 IL2RA LAPTM5	9.34e-05	165	64	4	004d793bf5bb6fb3b7bf38baf11b32d46375fe4d
ToppCell	NS-control-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SULF2 ESR2 DEF6 NR4A3	9.34e-05	165	64	4	8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86
ToppCell	control-Myeloid-pDC\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SULF2 ESR2 DEF6 NR4A3	9.34e-05	165	64	4	243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	AGO2 DEF6 SPOCK2 NR3C1	9.56e-05	166	64	4	c73fce59256ad501864f44f76cfae2fc33b3777e
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	STAB2 ADAMTS9 NR2F2 FAM162B	9.56e-05	166	64	4	5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)\|356C / Donor, Lineage, Cell class and subclass (all cells)	STAB2 ADAMTS9 NR2F2 FAM162B	9.56e-05	166	64	4	6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c
ToppCell	facs-Heart-RV-3m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP7 STAB2 IL2RA LAPTM5	9.56e-05	166	64	4	c0fd3f3f5c3412746da279b856af0d28b9b70c5d
ToppCell	facs-Heart-RV-3m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP7 STAB2 IL2RA LAPTM5	9.56e-05	166	64	4	33c4876df43b4c1d100699bca47459918bd054d6
ToppCell	facs-Heart-RV-3m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP7 STAB2 IL2RA LAPTM5	9.56e-05	166	64	4	ac9b9df57d65ccbbf9ae3add50c5663efcd30dcb
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBNL1 DEF6 SPOCK2 USP20	9.78e-05	167	64	4	484de3ca4a905067c18d06995601479eef8fc15e
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STAB2 DEF6 IL2RA LAPTM5	9.78e-05	167	64	4	84551ee71f9d8d03d514711fc7ca4422c810140b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP7 SULF2 PTPRQ SPOCK2	1.00e-04	168	64	4	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP7 SULF2 PTPRQ SPOCK2	1.00e-04	168	64	4	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP7 SULF2 PTPRQ SPOCK2	1.00e-04	168	64	4	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	SULF2 NR4A2 NR4A3 NR3C1	1.02e-04	169	64	4	71f6761b9927f352e0ccc221ca373319915f4184
Drug	AC1L2E0P	CLU ESR2 NR4A2 NR4A3 NR3C1 HNF4A HNF4G RXRB NR2F2	1.23e-07	307	61	9	CID000019390
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	STAB2 ARHGEF4 NR3C1 SCEL ZZEF1 ADCY7 MBNL3	8.36e-07	193	61	7	6938_UP
Drug	2,3,2-tet	HNF4A HNF4G NR2F2	1.52e-06	9	61	3	CID000078479
Drug	DR-0	HNF4A HNF4G RXRB NR2F2	2.29e-06	35	61	4	CID010062716
Drug	Raloxifene Hydrochloride	BMP7 AGO2 HMCN1 CLU MAPKAPK2 ESR2 NR4A3 NR3C1 HNF4A NOS2 RXRB GFRA2	2.39e-06	857	61	12	ctd:D020849
Drug	2,4,4'-trichlorobiphenyl	STAB2 AGO4 BAZ2B MYO1H ESR2 GPR75 RTP2 NR4A2 RFFL NR3C1 HNF4G IL2RA GFRA2 MBNL3 TTLL13	3.34e-06	1411	61	15	ctd:C081766
Drug	2,4,5,2',5'-pentachlorobiphenyl	STAB2 AGO4 BAZ2B MYO1H GPR75 RTP2 NR4A2 RFFL NR3C1 HNF4G IL2RA NOS2 GFRA2 MBNL3 TTLL13	4.32e-06	1441	61	15	ctd:C009828
Drug	Acetylcysteine	BMP7 RTP1 MAPKAPK2 ESR2 KREMEN2 NR4A2 SPOCK2 NR3C1 HNF4G IL2RA NOS2	6.23e-06	780	61	11	ctd:D000111
Drug	E-guggulsterone	ESR2 NR3C1 NOS2 RXRB NR2F2	1.05e-05	108	61	5	CID006439929
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A	DEF6 NR4A2 SPOCK2 ARHGEF4 NR3C1 HNF4A	1.41e-05	196	61	6	3210_UP
Drug	8-Bromo Cyclic Adenosine Monophosphate	ESR2 NR4A2 NR4A3 SPOCK2 ARHGEF4 NR3C1 HNF4G NOS2 ADCY7 RXRB	1.42e-05	693	61	10	ctd:D015124
Drug	Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A	ZBTB44 ADAMTS9 MAPKAPK2 SPOCK2 ARHGEF4 NR3C1	1.54e-05	199	61	6	6515_UP
Drug	undecan-2-one	ESR2 NR3C1	2.11e-05	3	61	2	ctd:C526928
Drug	CV-1	ESR2 NR3C1 HNF4A HNF4G RXRB NR2F2	2.26e-05	213	61	6	CID000130105
Drug	diheptyl phthalate	ESR2 NR4A2 RXRB	2.35e-05	21	61	3	ctd:C089799
Drug	LiCl	SPOCK2 NR3C1 HNF4A NOS2 ADCY7	2.99e-05	134	61	5	CID000433294
Drug	C3 P	HNF4A HNF4G NR2F2	4.04e-05	25	61	3	CID000066535
Drug	N-butylbenzenesulfonamide	ESR2 NR3C1	4.22e-05	4	61	2	ctd:C065565
Drug	Dexamethasone	NR3C1 NOS2	4.22e-05	4	61	2	DB01234
Drug	NSC-335754	NOS2 PMP2	4.22e-05	4	61	2	CID000333563
Drug	2,4,6-trimethylbenzaldehyde	ESR2 NR3C1	4.22e-05	4	61	2	ctd:C526470
Drug	cycloheptene	NR3C1 PMP2	4.22e-05	4	61	2	CID000012363
Drug	CDRI-85/287	ESR2 NR3C1 NR2F2	6.36e-05	29	61	3	CID000159508
Drug	Yellow pigment	MAPKAPK2 NR4A3 HNF4A NOS2	6.65e-05	81	61	4	CID000094326
Drug	uranium oxide	AGO4 PMP2	7.02e-05	5	61	2	CID000074013
Drug	2-tert-butylphenol	ESR2 RXRB	7.02e-05	5	61	2	ctd:C035406
Drug	trans-permethrin	RTP1 SCN1B RTP2 ADCY7	8.40e-05	86	61	4	CID000040159
Drug	3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide	ESR2 NR3C1	1.05e-04	6	61	2	ctd:C101850
Drug	5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol	ESR2 NOS2	1.05e-04	6	61	2	ctd:C120076
Drug	Peptide Bc-1nl	IL2RA NOS2	1.05e-04	6	61	2	CID000132929
Drug	Wy-14,643	NR3C1 HNF4A HNF4G NOS2 RXRB DNMT1	1.16e-04	286	61	6	CID000005694
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	KREMEN2 ARHGEF9 ARHGEF4 NR3C1 ADCY7	1.31e-04	183	61	5	6937_UP
Drug	cyclohexanal	NR3C1 PMP2	1.47e-04	7	61	2	CID000016275
Drug	methylthiourea	DNMT1 PMP2	1.47e-04	7	61	2	CID002723704
Drug	ethyl myristate	ESR2 NR3C1	1.47e-04	7	61	2	ctd:C032396
Drug	Dichlorodiphenyl Dichloroethylene	CLU ESR2 NR4A2 NR3C1 NOS2 RXRB	1.56e-04	302	61	6	ctd:D003633
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A	MAPKAPK2 MBNL1 ARHGEF9 NR4A2 NR3C1	1.68e-04	193	61	5	3209_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A	STAB2 ESR2 MBNL1 ZZEF1 NR2F2	1.68e-04	193	61	5	3021_UP
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	STAB2 MAPKAPK2 ARHGEF9 NR4A2 NR4A3	1.77e-04	195	61	5	1162_UP
Drug	Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A	BMP7 ZNF550 NR4A3 IL2RA NR2F2	1.77e-04	195	61	5	3099_UP
Drug	Lindane	CLU ESR2 NR4A2 NR3C1 HNF4A NOS2 RXRB	1.78e-04	443	61	7	ctd:D001556
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ESR2 KREMEN2 ARHGEF9 NR3C1 MBNL3	1.81e-04	196	61	5	6781_UP
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	DEF6 ARHGEF4 NR3C1 SCEL ZZEF1	1.81e-04	196	61	5	918_UP
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	BMP7 SCEL ZZEF1 MBNL3 PMP2	1.81e-04	196	61	5	6715_UP
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A	MAPKAPK2 DEF6 ARHGEF9 NR3C1 PTK7	1.85e-04	197	61	5	4604_DN
Drug	Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A	ZBTB44 BMP7 SPOCK2 NR3C1 ZZEF1	1.85e-04	197	61	5	2839_UP
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	AGO4 ADAMTS9 SPOCK2 NR3C1 ZZEF1	1.85e-04	197	61	5	6089_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ZBTB44 MAPKAPK2 NR4A2 NR3C1 USP20	1.85e-04	197	61	5	3277_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A	BMP7 MAPKAPK2 KREMEN2 SCEL ZZEF1	1.85e-04	197	61	5	3693_UP
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HT_HG-U133A	NR4A2 SPOCK2 ARHGEF4 USP20 PMP2	1.90e-04	198	61	5	4095_UP
Drug	Ronidazole [7681-76-7]; Up 200; 20uM; MCF7; HT_HG-U133A	STAB2 DEF6 SPOCK2 HNF4A PMP2	1.90e-04	198	61	5	3557_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	BMP7 ESR2 NR4A2 HNF4A IL2RA	1.90e-04	198	61	5	6630_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ZBTB44 KREMEN2 SPOCK2 MBNL3 LAPTM5	1.94e-04	199	61	5	2315_UP
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	STAB2 AGO4 MAPKAPK2 ZZEF1 PTK7	1.94e-04	199	61	5	5103_UP
Drug	4-hydroxyethynylestradiol	ESR2 NR3C1	1.96e-04	8	61	2	CID000066396
Drug	factor T	NR3C1 HNF4A	1.96e-04	8	61	2	CID000452319
Drug	fraxidin	CLU NOS2	1.96e-04	8	61	2	CID003083616
Drug	Plant Preparations	CLU ESR2 SLC13A5 HNF4A NOS2 GFRA2	1.96e-04	315	61	6	ctd:D028321
Drug	Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; HL60; HG-U133A	BMP7 STAB2 ESR2 NOS2 NR2F2	1.99e-04	200	61	5	1741_UP
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A	STAB2 NR4A2 NR4A3 SGCE IL2RA	1.99e-04	200	61	5	4387_UP
Drug	Aztreonam [78110-38-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	STAB2 SPOCK2 NR3C1 HNF4A LAPTM5	1.99e-04	200	61	5	5535_UP
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; HL60; HT_HG-U133A	BMP7 STAB2 GPR75 SCEL ZZEF1	1.99e-04	200	61	5	3019_UP
Disease	maturity-onset diabetes of the young type 1 (implicated_via_orthology)	HNF4A HNF4G	4.34e-06	2	62	2	DOID:0111099 (implicated_via_orthology)
Disease	obesity (implicated_via_orthology)	KDM3A BMP7 ADAMTS9 ESR2 NR3C1 HNF4A	6.11e-06	215	62	6	DOID:9970 (implicated_via_orthology)
Disease	Major Depressive Disorder	BMP7 ESR2 NR4A2 NR3C1 IL2RA ADCY7	1.23e-05	243	62	6	C1269683
Disease	myotonic disease (implicated_via_orthology)	MBNL1 MBNL3	1.30e-05	3	62	2	DOID:450 (implicated_via_orthology)
Disease	Unipolar Depression	BMP7 ESR2 NR4A2 NR3C1 IL2RA ADCY7	1.76e-05	259	62	6	C0041696
Disease	Endometrioma	BMP7 SULF2 ESR2 NR3C1 NR2F2	2.29e-05	161	62	5	C0269102
Disease	Endometriosis	BMP7 SULF2 ESR2 NR3C1 NR2F2	2.29e-05	161	62	5	C0014175
Disease	Fanconi syndrome (implicated_via_orthology)	HNF4A HNF4G	2.60e-05	4	62	2	DOID:1062 (implicated_via_orthology)
Disease	myotonic dystrophy type 2 (implicated_via_orthology)	MBNL1 MBNL3	4.33e-05	5	62	2	DOID:0050759 (implicated_via_orthology)
Disease	scoliosis (implicated_via_orthology)	ADAMTS9 PTK7	4.33e-05	5	62	2	DOID:0060249 (implicated_via_orthology)
Disease	asthma (implicated_via_orthology)	NR3C1 IL2RA NOS2	5.51e-05	35	62	3	DOID:2841 (implicated_via_orthology)
Disease	myotonic dystrophy type 1 (implicated_via_orthology)	MBNL1 MBNL3	6.48e-05	6	62	2	DOID:11722 (implicated_via_orthology)
Disease	Schizophrenia	CLU ESR2 MBNL1 NR4A2 NR3C1 IL2RA ADCY7 DNMT1 PMP2	9.05e-05	883	62	9	C0036341
Disease	Thyroid preparation use measurement	AGO2 BAZ2B NR3C1 IL2RA ADCY7	9.45e-05	217	62	5	EFO_0009933
Disease	systemic lupus erythematosus (is_marker_for)	CLU ESR2 DNMT1	1.34e-04	47	62	3	DOID:9074 (is_marker_for)
Disease	Cocaine Abuse	AGO2 ESR2 NR4A2 NR3C1	1.50e-04	127	62	4	C0009171
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	CLU NR4A2 NR4A3 ADCY7	1.70e-04	131	62	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	CLU NR4A2 NR4A3 ADCY7	1.70e-04	131	62	4	C4552091
Disease	Juvenile arthritis	CLU NR4A2 NR4A3 ADCY7	1.70e-04	131	62	4	C3495559
Disease	Juvenile psoriatic arthritis	CLU NR4A2 NR4A3 ADCY7	1.70e-04	131	62	4	C3714758
Disease	Juvenile-Onset Still Disease	CLU NR4A2 NR4A3 ADCY7	1.90e-04	135	62	4	C0087031
Disease	maturity-onset diabetes of the young (implicated_via_orthology)	HNF4A HNF4G	1.93e-04	10	62	2	DOID:0050524 (implicated_via_orthology)
Disease	Prostatic Intraepithelial Neoplasias	ESR2 DNMT1	2.36e-04	11	62	2	C0282612
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	SCN1B HNF4A NOS2 DNMT1	2.64e-04	147	62	4	DOID:9352 (biomarker_via_orthology)
Disease	Prostatic Neoplasms	KMT2C BMP7 STAB2 CLU ESR2 NR3C1 DNMT1	3.04e-04	616	62	7	C0033578
Disease	Malignant neoplasm of prostate	KMT2C BMP7 STAB2 CLU ESR2 NR3C1 DNMT1	3.04e-04	616	62	7	C0376358
Disease	prostate cancer (is_marker_for)	KDM3A KMT2C BMP7 DNMT1	3.30e-04	156	62	4	DOID:10283 (is_marker_for)
Disease	Arthritis, Psoriatic	NR4A2 NOS2	3.89e-04	14	62	2	C0003872
Disease	response to ketamine	DOCK8 MBNL1 NR3C1	4.19e-04	69	62	3	EFO_0009748
Disease	phospholipids in large HDL measurement	SULF2 MYO1H HNF4A	4.95e-04	73	62	3	EFO_0022190
Disease	Sjogren's syndrome (implicated_via_orthology)	MUC19 IL2RA	5.79e-04	17	62	2	DOID:12894 (implicated_via_orthology)
Disease	wellbeing measurement	BAZ2B MYO1H MBNL1 PTPRQ NR4A2 MUC19 SPOCK2	6.08e-04	692	62	7	EFO_0007869
Disease	depressive disorder (implicated_via_orthology)	ESR2 NR3C1	9.77e-04	22	62	2	DOID:1596 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	KMT2C DOCK8 PTK7	1.00e-03	93	62	3	C1535926
Disease	atrial fibrillation	KDM3A SULF2 POLD1 ESR2 NR3C1	1.10e-03	371	62	5	EFO_0000275
Disease	Intrahepatic Cholangiocarcinoma	KMT2C NOS2	1.16e-03	24	62	2	C0345905
Disease	low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram	SULF2 GFRA2	1.16e-03	24	62	2	EFO_0004611, EFO_0006329, EFO_0007871
Disease	Extrahepatic Cholangiocarcinoma	KMT2C NOS2	1.16e-03	24	62	2	C3805278
Disease	inflammatory bowel disease (implicated_via_orthology)	ESR2 IL2RA	1.26e-03	25	62	2	DOID:0050589 (implicated_via_orthology)
Disease	pre-eclampsia (is_implicated_in)	CLU ESR2	1.26e-03	25	62	2	DOID:10591 (is_implicated_in)
Disease	interstitial lung disease (is_marker_for)	NR3C1 NOS2	1.26e-03	25	62	2	DOID:3082 (is_marker_for)
Disease	brain ischemia (biomarker_via_orthology)	CLU ESR2 NR3C1	1.31e-03	102	62	3	DOID:2316 (biomarker_via_orthology)
Disease	diabetes mellitus (implicated_via_orthology)	BMP7 IL2RA	1.37e-03	26	62	2	DOID:9351 (implicated_via_orthology)
Disease	Cholangiocarcinoma	KMT2C NOS2	1.37e-03	26	62	2	C0206698
Disease	type 2 diabetes mellitus (implicated_via_orthology)	ADAMTS9 NR3C1 NR2F2	1.42e-03	105	62	3	DOID:9352 (implicated_via_orthology)
Disease	lipoprotein measurement	SULF2 MYO1H HNF4A	1.42e-03	105	62	3	EFO_0004732
Disease	age at menarche	SULF2 IQCH MYO1H NR4A2 HNF4G PTK7	1.54e-03	594	62	6	EFO_0004703
Disease	hepatocellular carcinoma (biomarker_via_orthology)	HNF4A NOS2 DNMT1	1.54e-03	108	62	3	DOID:684 (biomarker_via_orthology)
Disease	Subfertility, Female	ESR2 NR2F2	1.59e-03	28	62	2	C0341869
Disease	Sterility, Postpartum	ESR2 NR2F2	1.59e-03	28	62	2	C0038279
Disease	Female sterility	ESR2 NR2F2	1.59e-03	28	62	2	C0917730
Disease	Female infertility	ESR2 NR2F2	1.59e-03	28	62	2	C0021361
Disease	obstructive sleep apnea (is_marker_for)	NR3C1 NOS2	1.70e-03	29	62	2	DOID:0050848 (is_marker_for)
Disease	Malignant neoplasm of breast	KDM3A RTP1 SULF2 ESR2 ARHGEF4 NOS2 RXRB DNMT1	1.78e-03	1074	62	8	C0006142
Disease	anti-basement membrane glomerulonephritis (biomarker_via_orthology)	CLU NOS2	1.82e-03	30	62	2	DOID:4780 (biomarker_via_orthology)
Disease	Carcinoma, Granular Cell	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0205644
Disease	Adenocarcinoma, Tubular	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0205645
Disease	Adenocarcinoma, Oxyphilic	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0205642
Disease	Carcinoma, Cribriform	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0205643
Disease	Adenocarcinoma, Basal Cell	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0205641
Disease	Adenocarcinoma	KMT2C ESR2 DNMT1	1.89e-03	116	62	3	C0001418
Disease	Cocaine-Related Disorders	AGO2 ESR2 NR3C1	1.94e-03	117	62	3	C0236736
Disease	apolipoprotein A 1 measurement	BMP7 SULF2 MYO1H MBNL1 DEF6 DGKZ HNF4A	1.97e-03	848	62	7	EFO_0004614
Disease	Mental Depression	SGCE NR3C1 NOS2 ADCY7	2.02e-03	254	62	4	C0011570
Disease	pulmonary sarcoidosis (is_marker_for)	NR3C1 NOS2	2.07e-03	32	62	2	DOID:13406 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KLTLRCLVRMGYQCT	DNMT1	1281	P26358
EKSIMKVYCQICRKG	BAZ2B	1926	Q9UIF8
ICEGYVRQCRKRADM	ARHGEF4	306	Q9NR80
AIRGMISEYKANKRC	ANKRD62	251	A6NC57
HCGQMKRKYRVCNVT	AGO4	261	Q9HCK5
KANECMRIKILGDCY	ADCY7	316	P51828
ILKKYRNMVVRACGC	BMP7	416	P18075
HCGQMKRKYRVCNVT	AGO2	271	Q9UKV8
CEGYLKQCRKRRDMF	ARHGEF9	126	O43307
CQYCRLKKCLKVGMR	NR2F2	131	P24468
YLCLQIGKACRMRDV	IQCH	801	Q86VS3
NPKVVCMDKYRLSCL	NOS2	566	P35228
ELALRRGLQMKCVFC	KMT2C	4451	Q8NEZ4
NLYAGRKCLLIVMEC	MAPKAPK2	126	P49137
LRKCYEVGMVKCGSR	ESR2	206	Q92731
QCRYCRLKKCFRAGM	HNF4A	111	P41235
VIYSGCKKRVQMAKC	MUC19	8301	Q7Z5P9
KLTVQVCLRFCRMKG	KREMEN2	146	Q8NCW0
VCLRFCRMKGYQLAG	KREMEN2	151	Q8NCW0
CRYRKCLQAGMNLEA	NR3C1	476	P04150
MKYCKKQCRRLGHRV	MLKL	21	Q8NB16
LGFFCCKQKTRLRAM	GPR75	396	O95800
YCRLRKCFRAGMKKE	HNF4G	66	Q14541
YQLKGRKCMDVNECR	HMCN1	5221	Q96RW7
LVMLTQCFEKGRIRC	PTPRQ	2131	Q9UMZ3
LMKDRCKLFCRVAGN	ADAMTS9	681	Q9P2N4
FGVCVDCYRMKRKNC	KDM3A	681	Q9Y4C1
NKLRLCFKEFIMRCG	DOCK8	2011	Q8NF50
YDCRCKRGMKKELQC	GFRA2	91	O00451
RYIKRCLGALPAACM	GLYATL1B	196	A0A0U1RQE8
RLIMRCMKYLCQKNI	GLYATL1B	246	A0A0U1RQE8
GCKQLRILKMQYCTN	FBXL13	656	Q8NEE6
GKRCMFCVKTANRTY	DEF6	276	Q9H4E7
MLNCECKRGFRRIKS	IL2RA	46	P01589
CMDYIKGRCSREKCK	MBNL1	221	Q9NR56
CMDYIKGRCSREKCK	MBNL3	216	Q9NUK0
YCVARMLKSVSRRKC	DGKZ	116	Q13574
RKRLCKAMTLCICYA	SLC13A5	201	Q86YT5
CTSRDCPIFYMRKKV	POLD1	1071	P28340
ARNKARVKACYIMIG	FAM162B	101	Q5T6X4
QYCRFQKCLAVGMVK	NR4A2	316	P43354
YCRFQKCLSVGMVKE	NR4A3	346	Q92570
GSVRMRVFKQLCYEC	RTP1	121	P59025
SVRMRVFKQLCYECG	RTP2	86	Q5QGT7
RCYRLIKCMNSVEEK	LAPTM5	211	Q13571
GKRMNECPICRQYVI	RFFL	341	Q8WZ73
AYIMCCRREGVEKRN	SGCE	336	O43556
RYQKCLATGMKREAV	RXRB	261	P28702
YRARMKCQRKGGVLA	CLEC18A	321	A5D8T8
YRARMKCQRKGGVLA	CLEC18B	321	Q6UXF7
YRARMKCQRKGGVLA	CLEC18C	321	Q8NCF0
CLKQTCMKFYARVCR	CLU	116	P10909
CTYCRKPLGVETKMI	SCEL	621	O95171
VYGMTFKILCISCKR	SCN1B	31	Q07699
IRKPRIYECKTCGAM	ZBTB44	481	Q8NCP5
RMKDVNCTCKVGYVG	STAB2	2291	Q8WWQ8
NMYSCERCKKLRNGV	USP20	556	Q9Y2K6
RICVALSRAKKGMYC	ZNFX1	1216	Q9P2E3
CLECGKAFKRRSYLM	ZNF550	261	Q7Z398
CRVAKYLMVKFLCTR	ZZEF1	671	O43149
IIAVLGLMFYCKKRC	PTK7	716	Q13308
MELRSCKGYKQCNPR	SULF2	811	Q8IWU5
CIAQGYQRAMCISRK	SPOCK2	101	Q92563
KYESVRRAAQMCGLK	TTLL13	96	A6NNM8
LLRKMCVRNLVQKYC	MYO1H	816	Q8N1T3
VQKYCRGITAERKAM	MYO1H	826	Q8N1T3
AECKMKGVVCTRIYE	PMP2	116	P02689